Volume 61 Received 12 October 2005 | ||||||||||
| ||||||||||
aDepartment of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, England,bDepartment of Chemistry, Yozgat Faculty of Arts and Sciences, Erciyes University, 66200-Yozgat, Turkey, and cDepartment of Physics, Yozgat Faculty of Arts and Sciences, Erciyes University, 66200-Yozgat, Turkey
Correspondence e-mail: h.adams@sheffield.ac.uk
The structure of the title compound, C41H35N3O5, is stabilized by intra- and intermolecular C-H
O hydrogen bonds.
Pyrrolo[2,3]pyrimidines are an important class of compounds that are structurally and chemically related to nucleosides and some antibiotics (Ohgi et al., 1979
; Tolmann et al., 1968
). The well known biological activity of these compounds has led to intensive investigation of their use as antitumor, anti-allergic, antiviral and anti-inflammatory agents (Hutzenlaub et al., 1972
; Smith et al., 1972
).
In the light of this, we have synthesized and characterized the title compound, (2)
, and have determined its structure by X-ray analysis.
Fig. 1
shows the molecular structure of (2)
, with the atomic numbering scheme. The six-membered non-aromatic ring (C2/C1/N1/C5/N2/C6) has a total puckering amplitude of 0.532 (3) Å (Cremer & Pople, 1975
) and a boat conformation [
= 179.5 (4)° and
= 105.0 (5)°]. The five-membered aromatic ring (C1-C4/N3) and the five benzene rings (C7-C12, C13-C18, C19-C24, C25-C30 and C31-C36) are each essentially planar, with r.m.s. deviations of 0.0296 (13), 0.0104 (14), 0.0069 (15), 0.0067 (15), 0.046 (16) and 0.126 (15) Å, respectively. The bond lengths and angles are in agreement with reported literature values (Allen et al., 1987
).
The structure is stabilized by intra- and intermolecular C-H
O hydrogen bonds (Table 1
). In the crystal structure, the C-H
O intermolecular hydrogen bonds link the molecules into dimers which are stacked along the b axis (Fig. 2
).
| Figure 1 The molecular structure of (2) , with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms have been omitted. |
| Figure 2 Packing diagram of (2) ; C-H O hydrogen bonds are shown as dashed lines. |
Compound (1) was prepared from the cyclocondensation reaction that occurs between p,p'-dimethoxydibenzoylketene and oxalyl chloride (Hökelek et al., 2002
). Compound (2) was obtained from (1) (1.0 g, 2.96 mmol) by reaction with an excess of p-tolyl isocyanate in a 25 ml round-bottomed flask equipped with a calcium chloride tube. The mixture was heated at 338 K for 24 h. After cooling to room temperature, the residue was triturated with anhydrous diethyl ether, and the crude product was recrystallized from ethanol (yield 1.26 g, 66%; m.p. 475 K). IR (KBr, cm-1):
1727 (C3-O1), 1709 (C4-O2), 1684 (C5-O3); 1H NMR (CDCl3, p.p.m..):
7.64-6.04 (m, 20H, Ar-H), 3.88, 3.77 (s, 6H, CH3O), 2.25, 2.18, 2.15 (s, 9H, Ar-CH3); 13C NMR (CDCl3, p.p.m..):
178.51 (C3-O1), 165.58 (C4-O2), 164.47 (C5-O3), 162.35-115.52 (C=C, arom. and aliph.), 81.36 (N1-C1-N2), 57.50 (O4-C38), 57.28 (O5-C37), 23.00, 22.94, 22.92 (Ar-CH3). Analysis calculated for C41H35N3O5: C 75.80, H 5.39, N 6.47%; found: C 76.02, H 5.69, N 6.22%.
|
|
|
H atoms were positioned geometrically [0.95 (CH) and 0.98 Å (CH3)] and constrained to ride on their parent atoms, with Uiso(H) values of 1.2 (1.5 for methyl) times Ueq.
Data collection: SMART (Bruker, 1997
); cell refinement: SAINT (Bruker, 1997
); data reduction: SHELXTL (Bruker, 1997
); program(s) used to solve structure: SHELXS97 (Sheldrick, 1997
); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997
); molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL.
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L. & Orpen, A. G. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bruker (1997). SMART, SAINT, SHELXTL and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Hökelek, T., Saripinar, E., Yildirim, I., Akkurt, M. & Akçamur, Y. (2002). Acta Cryst. E58, o30-o32. ![[details]](../../../../../../e/graphics/details.gif)
Hutzenlaub, W., Tolman, R. L. & Robins, R. K. (1972). J. Med. Chem. 15, 879-883.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Ohgi, T., Kondo, T. & Goto, T. (1979). J. Am. Chem. Soc. 101, 3629-3633.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (1997). SHELXL97 and SHELXS97. University of Göttingen, Germany.
Smith, C. W., Sidwell, R. W., Robins, R. K. & Tolman, R. L. (1972). J. Med. Chem. 15, 883-887.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Tolmann, R. L., Robins, R. K. & Townsend, L. B. (1968). J. Am. Chem. Soc. 90, 524-526.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)